Matrix metalloproteinase (MMP) 9 transcription in mouse brain induced by fear learning. 2013

Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
From the Laboratory of Neurobiology and. Electronic address: k.ganguly@nencki.gov.pl.

Memory formation requires learning-based molecular and structural changes in neurons, whereas matrix metalloproteinase (MMP) 9 is involved in the synaptic plasticity by cleaving extracellular matrix proteins and, thus, is associated with learning processes in the mammalian brain. Because the mechanisms of MMP-9 transcription in the brain are poorly understood, this study aimed to elucidate regulation of MMP-9 gene expression in the mouse brain after fear learning. We show here that contextual fear conditioning markedly increases MMP-9 transcription, followed by enhanced enzymatic levels in the three major brain structures implicated in fear learning, i.e. the amygdala, hippocampus, and prefrontal cortex. To reveal the role of AP-1 transcription factor in MMP-9 gene expression, we have used reporter gene constructs with specifically mutated AP-1 gene promoter sites. The constructs were introduced into the medial prefrontal cortex of neonatal mouse pups by electroporation, and the regulation of MMP-9 transcription was studied after contextual fear conditioning in the adult animals. Specifically, -42/-50- and -478/-486-bp AP-1 binding motifs of the mouse MMP-9 promoter sequence have been found to play a major role in MMP-9 gene activation. Furthermore, increases in MMP-9 gene promoter binding by the AP-1 transcription factor proteins c-Fos and c-Jun have been demonstrated in all three brain structures under investigation. Hence, our results suggest that AP-1 acts as a positive regulator of MMP-9 transcription in the brain following fear learning.

UI MeSH Term Description Entries
D007858 Learning Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. Phenomenography
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
January 2010, Acta histochemica,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
July 2007, Journal of assisted reproduction and genetics,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
December 1998, Medical and pediatric oncology,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
December 2015, Neuromolecular medicine,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
July 2023, International journal of molecular sciences,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
June 1999, Journal of Korean medical science,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
March 2023, Biomedicines,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
January 2005, Experimental lung research,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
February 2017, Inflammation,
Krishnendu Ganguly, and Emilia Rejmak, and Marta Mikosz, and Evgeni Nikolaev, and Ewelina Knapska, and Leszek Kaczmarek
June 2012, Medical oncology (Northwood, London, England),
Copied contents to your clipboard!